| 20/11/2024 | Major shareholder disclosure in Navamedic ASA |
| 19/11/2024 | Flaggemelding Navamedic (NAVA) |
| 15/11/2024 | Navamedic ASA: Amendments to loan agreements with Observe Medical ASA |
| 06/11/2024 | Navamedic ASA: Mandatory notice of trade |
| 06/11/2024 | Navamedic launches Eroxon[®] in Finland |